# Charu Aggarwal, MD, MPH, Hematology-Oncology Division – FDA Inspection, Mar 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/charu-aggarwal-md-mph-hematology-oncology-division/47299dc4-c9e5-426e-b63d-33cf9ceec5b8
Source feed: FDA_Inspections

> FDA inspection 1017164 of Charu Aggarwal, MD, MPH, Hematology-Oncology Division, March 28, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017164
- Company Name: Charu Aggarwal, MD, MPH, Hematology-Oncology Division
- Inspection Date: 2017-03-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1331848 - 2026-07-20

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/charu-aggarwal-md-mph-hematology-oncology-division/8e6529bd-6bbe-400c-a06b-816a5ff26a98

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
